Tramadol Hydrochloride Tablet, Extended Release
Product Images NDC 63629-8323

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tramadol Hydrochloride (NDC 63629-8323). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image-1 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 01)

Chemical structure of tramadol hydrochloride showing its molecular arrangement including a methoxyphenyl group and a cyclohexanol moiety with an attached dimethylaminoethyl side chain.*

FDA Label Image

Image-2 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 02)

A line graph comparing tramadol concentration (ng/mL) over 24 hours for Tramadol Hydrochloride Extended-Release Tablets 200 mg once daily versus Tramadol Hydrochloride Tablets 50 mg every 6 hours. The x-axis represents time in hours, and the y-axis shows tramadol concentration in ng/mL, illustrating the pharmacokinetic profiles of the two formulations.*

FDA Label Image

Image-3 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 03)

A line graph depicting M1 concentration (ng/mL) over 24 hours comparing Tramadol Hydrochloride Extended-Release Tablets, 200 mg q.d. and Tramadol Hydrochloride Tablets, 50 mg q6h. The x-axis shows time in hours; the y-axis shows M1 concentration. Two trends with solid and open circle markers are displayed.*

FDA Label Image

Image-4 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 04)

Line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 023 WOMAC Pain Responder Analysis,' showing percent of patients achieving response on the y-axis and response threshold (percent improvement from baseline) on the x-axis. The graph compares various doses of Tramadol Hydrochloride Extended-Release Tablets (100 mg, 200 mg, 300 mg, 400 mg) and placebo, with response rates generally decreasing as the response threshold increases.*

FDA Label Image

Image-5 (7848ebcb 7a13 48a8 Bbeb 7481d040c068 05)

A line graph titled 'Tramadol Hydrochloride Extended-Release Tablets Study 015 Arthritis Pain Intensity VAS Responder Analysis.' It shows the percent of patients achieving various response thresholds of pain improvement from baseline, comparing Tramadol Hydrochloride Extended-Release Tablets and placebo. The x-axis represents the response threshold in percent improvement, and the y-axis shows the percentage of patients achieving response. Two lines compare response rates, with Tramadol consistently higher than placebo.*

FDA Label Image

Label (Lbl636298323)

Label for Tramadol ER 100 mg extended-release tablet, packaged by Bryant Ranch Prepack in Burbank, CA. The label shows the product strength and form, compares it to Ultram ER 100 mg tablet by Lupin Limited, and includes storage instructions at 20°-25°C (68°-77°F). The label also displays a lot number, NDC 63629-8323-1, and a barcode, with warnings to keep drugs out of reach of children. The tablet is described as white and round.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.